Trials / Completed
CompletedNCT04113564
Absolute Oral Bioavailability of Remimazolam
A Randomized, Open-label, Single-dose, 2-way Crossover Study to Compare the Relative Bioavailability of Orally Administered Remimazolam to an Intravenous Formulation in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Paion UK Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A randomized, open-label, single-dose, 2-way crossover study to compare the relative bioavailability of orally administered remimazolam to an intravenous formulation in healthy volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Remimazolam |
Timeline
- Start date
- 2015-11-03
- Primary completion
- 2015-11-20
- Completion
- 2015-11-20
- First posted
- 2019-10-02
- Last updated
- 2019-10-02
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04113564. Inclusion in this directory is not an endorsement.